Global Human Microbiome Market Research Report 2022
SKU ID : QYR-21041036 | Publishing Date : 08-Jun-2022
Detailed TOC of Global Human Microbiome Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2017-2028)
2.2 Human Microbiome Growth Trends by Region
2.2.1 Human Microbiome Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Microbiome Historic Market Size by Region (2017-2022)
2.2.3 Human Microbiome Forecasted Market Size by Region (2023-2028)
2.3 Human Microbiome Market Dynamics
2.3.1 Human Microbiome Industry Trends
2.3.2 Human Microbiome Market Drivers
2.3.3 Human Microbiome Market Challenges
2.3.4 Human Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Players by Revenue
3.1.1 Global Top Human Microbiome Players by Revenue (2017-2022)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2017-2022)
3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Revenue
3.4 Global Human Microbiome Market Concentration Ratio
3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2021
3.5 Human Microbiome Key Players Head office and Area Served
3.6 Key Players Human Microbiome Product Solution and Service
3.7 Date of Enter into Human Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Breakdown Data by Type
4.1 Global Human Microbiome Historic Market Size by Type (2017-2022)
4.2 Global Human Microbiome Forecasted Market Size by Type (2023-2028)
5 Human Microbiome Breakdown Data by Application
5.1 Global Human Microbiome Historic Market Size by Application (2017-2022)
5.2 Global Human Microbiome Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Microbiome Market Size (2017-2028)
6.2 North America Human Microbiome Market Size by Country (2017-2022)
6.3 North America Human Microbiome Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Human Microbiome Market Size (2017-2028)
7.2 Europe Human Microbiome Market Size by Country (2017-2022)
7.3 Europe Human Microbiome Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Market Size (2017-2028)
8.2 Asia-Pacific Human Microbiome Market Size by Country (2017-2022)
8.3 Asia-Pacific Human Microbiome Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Human Microbiome Market Size (2017-2028)
9.2 Latin America Human Microbiome Market Size by Country (2017-2022)
9.3 Latin America Human Microbiome Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Market Size (2017-2028)
10.2 Middle East & Africa Human Microbiome Market Size by Country (2017-2022)
10.3 Middle East & Africa Human Microbiome Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Vedanta
11.1.1 Vedanta Company Detail
11.1.2 Vedanta Business Overview
11.1.3 Vedanta Human Microbiome Introduction
11.1.4 Vedanta Revenue in Human Microbiome Business (2017-2022)
11.1.5 Vedanta Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Detail
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2017-2022)
11.2.5 Seres Therapeutics Recent Development
11.3 Second Genome
11.3.1 Second Genome Company Detail
11.3.2 Second Genome Business Overview
11.3.3 Second Genome Human Microbiome Introduction
11.3.4 Second Genome Revenue in Human Microbiome Business (2017-2022)
11.3.5 Second Genome Recent Development
11.4 Rebiotix
11.4.1 Rebiotix Company Detail
11.4.2 Rebiotix Business Overview
11.4.3 Rebiotix Human Microbiome Introduction
11.4.4 Rebiotix Revenue in Human Microbiome Business (2017-2022)
11.4.5 Rebiotix Recent Development
11.5 ActoGeniX
11.5.1 ActoGeniX Company Detail
11.5.2 ActoGeniX Business Overview
11.5.3 ActoGeniX Human Microbiome Introduction
11.5.4 ActoGeniX Revenue in Human Microbiome Business (2017-2022)
11.5.5 ActoGeniX Recent Development
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Detail
11.6.2 Enterome BioScience Business Overview
11.6.3 Enterome BioScience Human Microbiome Introduction
11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2017-2022)
11.6.5 Enterome BioScience Recent Development
11.7 AvidBiotics
11.7.1 AvidBiotics Company Detail
11.7.2 AvidBiotics Business Overview
11.7.3 AvidBiotics Human Microbiome Introduction
11.7.4 AvidBiotics Revenue in Human Microbiome Business (2017-2022)
11.7.5 AvidBiotics Recent Development
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Detail
11.8.2 4D Pharma Research Ltd Business Overview
11.8.3 4D Pharma Research Ltd Human Microbiome Introduction
11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022)
11.8.5 4D Pharma Research Ltd Recent Development
11.9 Enterologics
11.9.1 Enterologics Company Detail
11.9.2 Enterologics Business Overview
11.9.3 Enterologics Human Microbiome Introduction
11.9.4 Enterologics Revenue in Human Microbiome Business (2017-2022)
11.9.5 Enterologics Recent Development
11.10 Metabogen
11.10.1 Metabogen Company Detail
11.10.2 Metabogen Business Overview
11.10.3 Metabogen Human Microbiome Introduction
11.10.4 Metabogen Revenue in Human Microbiome Business (2017-2022)
11.10.5 Metabogen Recent Development
11.11 Metabiomics
11.11.1 Metabiomics Company Detail
11.11.2 Metabiomics Business Overview
11.11.3 Metabiomics Human Microbiome Introduction
11.11.4 Metabiomics Revenue in Human Microbiome Business (2017-2022)
11.11.5 Metabiomics Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Detail
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022)
11.12.5 Ritter Pharmaceuticals Recent Development
11.13 Osel
11.13.1 Osel Company Detail
11.13.2 Osel Business Overview
11.13.3 Osel Human Microbiome Introduction
11.13.4 Osel Revenue in Human Microbiome Business (2017-2022)
11.13.5 Osel Recent Development
11.14 Symberix
11.14.1 Symberix Company Detail
11.14.2 Symberix Business Overview
11.14.3 Symberix Human Microbiome Introduction
11.14.4 Symberix Revenue in Human Microbiome Business (2017-2022)
11.14.5 Symberix Recent Development
11.15 Miomics
11.15.1 Miomics Company Detail
11.15.2 Miomics Business Overview
11.15.3 Miomics Human Microbiome Introduction
11.15.4 Miomics Revenue in Human Microbiome Business (2017-2022)
11.15.5 Miomics Recent Development
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Detail
11.16.2 Symbiotix Biotherapies Business Overview
11.16.3 Symbiotix Biotherapies Human Microbiome Introduction
11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022)
11.16.5 Symbiotix Biotherapies Recent Development
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Detail
11.17.2 MicroBiome Therapeutics LLC Business Overview
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022)
11.17.5 MicroBiome Therapeutics LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Human Microbiome Market Research Report 2022
List of TablesTable 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Gastrointestinal Tract Human Micobiome
Table 3. Key Players of Urogenital Tract Human Micobiome
Table 4. Key Players of Others
Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Human Microbiome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Human Microbiome Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Human Microbiome Market Share by Region (2017-2022)
Table 9. Global Human Microbiome Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Human Microbiome Market Share by Region (2023-2028)
Table 11. Human Microbiome Market Trends
Table 12. Human Microbiome Market Drivers
Table 13. Human Microbiome Market Challenges
Table 14. Human Microbiome Market Restraints
Table 15. Global Human Microbiome Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Human Microbiome Market Share by Players (2017-2022)
Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021)
Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Product Solution and Service
Table 22. Date of Enter into Human Microbiome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Human Microbiome Revenue Market Share by Type (2017-2022)
Table 26. Global Human Microbiome Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Human Microbiome Revenue Market Share by Type (2023-2028)
Table 28. Global Human Microbiome Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Human Microbiome Revenue Market Share by Application (2017-2022)
Table 30. Global Human Microbiome Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Human Microbiome Revenue Market Share by Application (2023-2028)
Table 32. North America Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Human Microbiome Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Human Microbiome Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Human Microbiome Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Human Microbiome Market Size by Country (2023-2028) & (US$ Million)
Table 42. Vedanta Company Detail
Table 43. Vedanta Business Overview
Table 44. Vedanta Human Microbiome Product
Table 45. Vedanta Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 46. Vedanta Recent Development
Table 47. Seres Therapeutics Company Detail
Table 48. Seres Therapeutics Business Overview
Table 49. Seres Therapeutics Human Microbiome Product
Table 50. Seres Therapeutics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 51. Seres Therapeutics Recent Development
Table 52. Second Genome Company Detail
Table 53. Second Genome Business Overview
Table 54. Second Genome Human Microbiome Product
Table 55. Second Genome Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 56. Second Genome Recent Development
Table 57. Rebiotix Company Detail
Table 58. Rebiotix Business Overview
Table 59. Rebiotix Human Microbiome Product
Table 60. Rebiotix Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 61. Rebiotix Recent Development
Table 62. ActoGeniX Company Detail
Table 63. ActoGeniX Business Overview
Table 64. ActoGeniX Human Microbiome Product
Table 65. ActoGeniX Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 66. ActoGeniX Recent Development
Table 67. Enterome BioScience Company Detail
Table 68. Enterome BioScience Business Overview
Table 69. Enterome BioScience Human Microbiome Product
Table 70. Enterome BioScience Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 71. Enterome BioScience Recent Development
Table 72. AvidBiotics Company Detail
Table 73. AvidBiotics Business Overview
Table 74. AvidBiotics Human Microbiome Product
Table 75. AvidBiotics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 76. AvidBiotics Recent Development
Table 77. 4D Pharma Research Ltd Company Detail
Table 78. 4D Pharma Research Ltd Business Overview
Table 79. 4D Pharma Research Ltd Human Microbiome Product
Table 80. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 81. 4D Pharma Research Ltd Recent Development
Table 82. Enterologics Company Detail
Table 83. Enterologics Business Overview
Table 84. Enterologics Human Microbiome Product
Table 85. Enterologics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 86. Enterologics Recent Development
Table 87. Metabogen Company Detail
Table 88. Metabogen Business Overview
Table 89. Metabogen Human Microbiome Product
Table 90. Metabogen Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 91. Metabogen Recent Development
Table 92. Metabiomics Company Detail
Table 93. Metabiomics Business Overview
Table 94. Metabiomics Human MicrobiomeProduct
Table 95. Metabiomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 96. Metabiomics Recent Development
Table 97. Ritter Pharmaceuticals Company Detail
Table 98. Ritter Pharmaceuticals Business Overview
Table 99. Ritter Pharmaceuticals Human MicrobiomeProduct
Table 100. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 101. Ritter Pharmaceuticals Recent Development
Table 102. Osel Company Detail
Table 103. Osel Business Overview
Table 104. Osel Human MicrobiomeProduct
Table 105. Osel Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 106. Osel Recent Development
Table 107. Symberix Company Detail
Table 108. Symberix Business Overview
Table 109. Symberix Human MicrobiomeProduct
Table 110. Symberix Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 111. Symberix Recent Development
Table 112. Miomics Company Detail
Table 113. Miomics Business Overview
Table 114. Miomics Human MicrobiomeProduct
Table 115. Miomics Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 116. Miomics Recent Development
Table 117. Symbiotix Biotherapies Company Detail
Table 118. Symbiotix Biotherapies Business Overview
Table 119. Symbiotix Biotherapies Human MicrobiomeProduct
Table 120. Symbiotix Biotherapies Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 121. Symbiotix Biotherapies Recent Development
Table 122. MicroBiome Therapeutics LLC Company Detail
Table 123. MicroBiome Therapeutics LLC Business Overview
Table 124. MicroBiome Therapeutics LLC Human MicrobiomeProduct
Table 125. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2017-2022) & (US$ Million)
Table 126. MicroBiome Therapeutics LLC Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Market Share by Type: 2021 VS 2028
Figure 2. Gastrointestinal Tract Human Micobiome Features
Figure 3. Urogenital Tract Human Micobiome Features
Figure 4. Others Features
Figure 5. Global Human Microbiome Market Share by Application in 2021 & 2028
Figure 6. Treatment Case Studies
Figure 7. Diagnosis Case Studies
Figure 8. Human Microbiome Report Years Considered
Figure 9. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Human Microbiome Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Human Microbiome Market Share by Region: 2021 VS 2028
Figure 12. Global Human Microbiome Market Share by Players in 2021
Figure 13. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2021
Figure 15. North America Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Human Microbiome Market Share by Country (2017-2028)
Figure 17. United States Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Human Microbiome Market Share by Country (2017-2028)
Figure 21. Germany Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Human Microbiome Market Share by Region (2017-2028)
Figure 29. China Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Human Microbiome Market Share by Country (2017-2028)
Figure 37. Mexico Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Human Microbiome Market Share by Country (2017-2028)
Figure 41. Turkey Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Human Microbiome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Vedanta Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 44. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 45. Second Genome Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 46. Rebiotix Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 47. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 48. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 49. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 50. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 51. Enterologics Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 52. Metabogen Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 53. Metabiomics Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 54. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 55. Osel Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 56. Symberix Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 57. Miomics Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 58. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 59. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Keyplayers in Global Human Microbiome Market Research Report 2022
VedantaSeres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC